Comparison of in-silico and in-vitro studies of benzimidazoleoxothiazolidine derivatives as m. Tubcerculosis transcriptor inhibitors
German Journal of Pharmaceuticals and Biomaterials · 2023
DOI: 10.5530/gjpb.2023.2.6 ↗Kurz gefasst
Fachartikel in der Zeitschrift German Journal of Pharmaceuticals and Biomaterials, 2023. Verfasst von Sonal Dubey und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dubey, S., Bhardwaj, S., Prabhakaran, P., Mandal, S. P., & Singh, E. (2023). Comparison of in-silico and in-vitro studies of benzimidazoleoxothiazolidine derivatives as m. Tubcerculosis transcriptor inhibitors. German Journal of Pharmaceuticals and Biomaterials. https://doi.org/10.5530/gjpb.2023.2.6
Vancouver
Dubey S, Bhardwaj S, Prabhakaran P, Mandal SP, Singh E. Comparison of in-silico and in-vitro studies of benzimidazoleoxothiazolidine derivatives as m. Tubcerculosis transcriptor inhibitors. German Journal of Pharmaceuticals and Biomaterials. 2023. doi:10.5530/gjpb.2023.2.6
BibTeX
@article{Dubey2023,
author = {Dubey, Sonal and Bhardwaj, Sakshi and Prabhakaran, Prabitha and Mandal, Subhankar Parboth and Singh, Ekta},
title = {Comparison of in-silico and in-vitro studies of benzimidazoleoxothiazolidine derivatives as m. Tubcerculosis transcriptor inhibitors},
journal = {German Journal of Pharmaceuticals and Biomaterials},
year = {2023},
doi = {10.5530/gjpb.2023.2.6}
}
EUVIMED